Lygos

Emeryville, United States Founded: 2010 • Age: 16 yrs
Green acids are produced from microbes via synthetic biology.

About Lygos

Lygos is a Chemicals & Materials company based in Emeryville (United States) founded in 2010 by Eric Steen. Green acids are produced from microbes via synthetic biology. It operates on a B2B2C model in Chemicals & Materials and Healthcare sectors. Lygos has raised $51.77 million across 24 funding rounds from investors including United States Department of Agriculture, Flexible Solutions and DOE. Lygos has completed 1 acquisition, including Librede. Its chief executive, as recorded, is Eric Steen. Lygos offers products and services including Soltellus TM, Agronomy Solutions, Home Care Solutions, Hygiene Solutions, and Personal Care Solutions. Its focus areas include Chemicals, Specialty Chemicals and Industrial Applications. Its legal entity is Lygos, Inc. Its competitors include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Specialty chemicals are produced by Lygos to enhance performance across multiple sectors including agronomy, home care, hygiene, personal care, and water treatment. Solutions are designed to improve crop yields, fight stains, balance sustainability with performance, enhance personal care formulations, and prevent corrosion in water systems. Practical innovations are delivered through material science and chemistry expertise, ensuring sustainable value at scale for customers without compromising on quality.

  • Headquarters Emeryville, United States
  • Founders Eric Steen
  • Sectors
    Chemicals & Materials
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website lygos.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Lygos, Inc.
Key Metrics

Products & Services of Lygos

Lygos offers a comprehensive portfolio of products and services, including Soltellus TM, Agronomy Solutions, Home Care Solutions, Hygiene Solutions, and Personal Care Solutions.

Soltellus TM
Specialty Chemicals

Specialty chemicals are developed for various industrial applications.

Agronomy Solutions
Agricultural Chemicals

Solutions are provided to increase crop yields effectively.

Home Care Solutions
Cleaning Chemicals

Products are designed to remove soil and stains.

Hygiene Solutions
Superabsorbent Polymers

Polymers are created for high performance and sustainability.

Personal Care Solutions
Cosmetic Chemicals

Formulations are improved for haircare and skincare products.

Water Treatment Solutions
Industrial Chemicals

Chemicals are used to prevent scale and corrosion.

Apps and channels of Lygos

its YouTube channel Lygos has 48 subscribers and 13 videos.

Lygos
YouTube 48 subscribers 13 videos Howto & Style
Open channel

Videos from Lygos

The most watched videos on Lygos's YouTube channel, Lygos (48 subscribers). Click a video to play it here.

Soltellus for Agronomy
502 views
Webinar Maximize Nutrient Uptake for Higher Yields
404 views
Lygos Agronomy Webinar: Field Trial Data Proves Soltellus ROI
307 views
Lygos - Better Materials for Better Products
303 views

More on Lygos.

Funding Insights of Lygos

Lygos has successfully raised a total of $51.77M across 24 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $51.77M
  • Total Rounds 24
  • First Round $150,000

    (Jun 2011)

  • Investors Count 17

Latest 10 of 24 funding rounds of Lygos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2021Series B–Flexible Solutions, NanoChem Solutions
–
Jul 2019$2MGrant––
Apr 2019$10.9MSeries B––
–
Jan 2019$5MSeries B–LG Technology Ventures
–
Dec 2018$5MSeries B–CJ CheilJedang
–
Aug 2018$91,515Grant––
Jul 2018$15.51MSeries B–IA Ventures, First Round Capital
Jul 2018$150,000Grant––
Dec 2016$14.06MSeries A–OS Fund, IA Ventures
Mar 2016$300,000Grant––
Valuation history

17 investors in total: 17 institutional.

Investors in Lygos

Lygos has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include United States Department of Agriculture, Flexible Solutions and DOE.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investment in early-stage companies across AI, biotech, and cleantech sectors with access to global resources.
lgtechventures.com
Seed and early-stage venture capital firm focusing on investments in technology and fintech companies
iaventures.comNew York, United States
US focused seed and early-stage VC firm
firstround.comSan Francisco, United States
Early-stage centric sector-agnostic VC firm investing in geographies such as the US
osfund.coChicago, United States
Early-stage startups are accelerated via funding and educational programs.
ycombinator.comMountain View, United States
US focused venture capital firm
vastvc.comNew York, United States
Venture capital firm focused on multiple sectors
fiftyyears.comSan Francisco, United States
Seed and early-stage US life-sciences and tech investments are targeted.
brainchild.coNew York, United States
Venture capital firm investing in multiple sectors
10x.groupMunich, Germany
Venture capital fund backed by the US Government
seedfund.nsf.govAlexandria, United States
Premium access

Investor details for Lygos

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Lygos

28 people are tracked at Lygos (13 in leadership, 7 in board & advisors, 8 in team).

NameRoleGroup
Eric Steen
Co-Founder & CEOLeadership
Jeremy Liu
Director, Project ManagementLeadership
Bryce Dille
CFOLeadership
Photon Rao
VP, Legal Affairs & Chief Patent CounselLeadership
Daniel Almirall
Senior Director Of Business DevelopmentLeadership
Liza Lopez
Vice President, Process Scale-up and ManufacturingLeadership
Connie Wong, CPA
Director, Assistant ControllerLeadership
Richard Weber
Chief Business OfficerLeadership
Binh Haynes
Site DirectorLeadership
Nicholas Spoden
Sr Director Of AgronomyLeadership
Rachel Cox Carlson
Head Of Supply ChainLeadership
Johan van Walsem
Chief Operations OfficerLeadership
Jon Hansen
Senior Vice President Of Biotechnology And Pilot OperationsLeadership
Jim Millis
AdvisorBoard & advisors
Michael Cockrem
AdvisorBoard & advisors
Charles Cooney
AdvisorBoard & advisors
Jay D. Keasling
Co Founder & AdvisorBoard & advisors
Leonard Katz
Co Founder & AdvisorBoard & advisors
Stephen Del Cardayre
AdvisorBoard & advisors
Richard Bailey
AdvisorBoard & advisors

8 more people are available in the full profile.

Premium access

Complete people profiles for Lygos

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Lygos

Lygos has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Librede.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Yeast is engineered via synthetic biology for cannabinoid compound production.
librede.comSan Diego, United States2009Jan 2020β€’β€’β€’β€’
Premium access

Complete acquisition details for Lygos

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Lygos

4 dated milestones of Lygos across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lygos is founded.
  2. Funding First funding round of $150K.
  3. Acquisition Acquires Librede.
  4. Funding Latest funding round, Series B,.

Competitors of Lygos

Lygos has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aviditybiosciences.com2012San Diego, United States$142.54M253
Antibody-siRNA complexes are developed for cancer treatment.
sutrobio.com2003United States$171.85M235
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
vividion.com2016Oceanside, United States$270.5M123
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Premium access

Detailed competitors of Lygos

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Lygos

The website of Lygos (lygos.com) receives about 5.2K visits a month.

  • Monthly visits
    5.2K

    ▲ 27.5% vs previous month

Similar websites

Websites whose visitors overlap most with Lygos. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
synbiobeta.com
100%
#979,192View details

Top companies in Chemicals Tech

3 companies that operate in the same segment as Lygos (Chemicals Tech) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Microbe-based plant protection products and yield optimization services are provided.
2013Boston, Massachusetts, United StatesUSD 1.4 B1,316
Conductive nanocoatings are delivered via atomic layer deposition technology.
2013Boulder, Colorado, United StatesUSD 202.75 M
Sustainable bio-based chemicals are manufactured using a proprietary platform.
2016Houston, Texas, United StatesUSD 656.05 M133
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lygos

Premium access

Complete news archive for Lygos

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lygos

Lygos was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Lygos is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.

Eric Steen is the CEO of Lygos, as recorded in our data. They have also founded this company.

Lygos is a funded company, having raised a total of $51.77M across 24 funding rounds to date. The company's 1st funding round was a Grant of $300K, raised on Jun 2011.

Specialty chemicals are produced by Lygos to enhance performance across multiple sectors including agronomy, home care, hygiene, personal care, and water treatment. Solutions are designed to improve crop yields, fight stains, balance sustainability with performance, enhance personal care formulations, and prevent corrosion in water systems. Practical innovations are delivered through material science and chemistry expertise, ensuring sustainable value at scale for customers without compromising on quality.

Lygos's top competitors include Sutro Biopharma, Avidity Biosciences and Vividion Therapeutics.

Lygos offers Soltellus TM, Agronomy Solutions, Home Care Solutions, Hygiene Solutions, and 2 more products and services.

Lygos has made 1 acquisition, including Librede.

Lygos operates through Lygos, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available